Lung Cancer Screening Clinical Study

Austin Regional Clinic physicians constantly try to improve the care given to all our patients. We are dedicated to offering unique options for our patients and helping them reach their ideal health goals. Part of this dedication involves making clinical research available. Clinical research makes it possible to discover the benefits, risks, and safety of commercially available and investigational medications.

Research standards are very strict to help make studies as safe as possible. Teams of government and research experts have already reviewed each study we conduct to minimize any study risks. Austin Regional Clinic has decided to be involved in this research study because we believe it can potentially benefit our patients.

About the lung cancer screening clinical study

Austin Regional Clinic is conducting a research study called the SHIELD study, which will support the development of a blood test to detect early stages of lung cancer for widespread use among individuals.

By participating in this study, you would be contributing to the development of groundbreaking technology with the potential to benefit many people in the future. ARC is one of the many study centers in the United States participating in this research study.

If you’d like to see if you qualify, please contact our research team. Call our ARC clinical research team at 512-225-5931.

What to expect

We are currently seeking candidates for a clinical research study at ARC Clinical Research William Cannon​.

  • Qualified volunteers will receive a $75 stipend after allowing a blood sample to be drawn by an experienced practitioner.
  • This study may last 1-2 years and may include an additional follow-up appointment.
  • You will be asked to consent to an investigational blood draw.
  • You will be undergoing a low dose CT scan of the chest for lung cancer screening.

Eligibility criteria

  • Participants must be willing to consent to the investigational blood draw.
  • Participants must be willing to consent to a 1-year, 2-year, and additional follow-up. 


Request to Participate